Journal of Clinical Oncology
Collection
Collection
- ISSN: 0732183X
Published by American Society of Clinical Oncology
Contains articles from around the world discussing the diagnosis, management, treatment, and prevention of cancer.
-
Impact of body-size measures on irinotecan clearance: Alternative dosing recommendations Article
Journal of Clinical Oncology, 20(1), 81-87.A.H.J. Mathijssen (Ron), J. Verweij (Jaap), M.J.A. de Jonge (Maja), K. Nooter (Kees), G. Stoter (Gerrit) and A. Sparreboom (Alex)
January 2002 -
Beneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: A randomized clinical trial Article
Journal of Clinical Oncology, 20(2), 371-378.H.J. Agteresch (Hendrik), T. Rietveld (Trinet), L.G. Kerkhofs (Leon), J.W.O. van den Berg (Willem), J.H.P. Wilson (Paul) and P.C. Dagnelie (Pieter)
January 2002 -
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: Urinary excretion predicts hematologic toxicity Article
Journal of Clinical Oncology, 20(5), 1222-1231.D.F.S. Kehrer (Diederik), A.M. Bos (Annelies), J. Verweij (Jaap), H.J.M. Groen (Henk), W.J. Loos (Walter), A. Sparreboom (Alex), M.J.A. de Jonge (Maja), M. Hamilton, T. Cameron (Terri) and E.G.E. de Vries (Elisabeth)
March 2002 -
Modulation of irinotecan metabolism by ketoconazole Article
Journal of Clinical Oncology, 20(14), 3122-3129.D.F.S. Kehrer (Diederik), A.H.J. Mathijssen (Ron), J. Verweij (Jaap), P.J. de Bruijn (Peter) and A. Sparreboom (Alex)
July 2002 -
Pharmacokinetics of irinotecan and its metabolites [4] (multiple letters) Article
Journal of Clinical Oncology, 20(23), 4609-4610.J. Siderov (Jim), A.H.J. Mathijssen (Ron), W.J. Loos (Walter), A. Sparreboom (Alex), J. Verweij (Jaap) and M.O. Karlsson
December 2002 -
Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel Article
Journal of Clinical Oncology, 21(2), 197-202.C.H. Smorenburg (Carolien), A. Sparreboom (Alex), M. Bontenbal (Marijke), G. Stoter (Gerrit), K. Nooter (Kees) and J. Verweij (Jaap)
January 2003 -
Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation Article
Journal of Clinical Oncology, 21(9), 1675-1681.E.J. Meijers-Heijboer (Hanne), C.T. Brekelmans (Cecile), M.B.E. Menke-Pluymers (Marian B.), C.M. Seynaeve (Caroline), A. Baalbergen (Astrid), C.W. Burger (Curt), E. Crepin (Ellen), A.M.W. van den Ouweland (Ans), B.N. van Geel (Bert) and J.G.M. Klijn (Jan)
May 2003 -
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome Review
B.W.G. van Rhijn (Bas), A.N. Vis (André), Th.H. van der Kwast (Theo), W.J. Kirkels (Wim), F. Radvanyi (Franois), E.C.M. Ooms (Engelbert C.), D.K. Chopin, E.R. Boeve, A.C. Jöbsis (Adriaan) and E.C. Zwarthoff (Ellen)
May 2003